US Dept of Labor

Occupational Safety & Health AdministrationWe Can Help

OSHA News Release - (Archived) Table of Contents
Archive Notice - OSHA Archive

NOTICE: This is an OSHA Archive Document, and may no longer represent OSHA Policy. It is presented here as historical content, for research and review purposes only.
Trade News Release Banner Image

Region 3 News Release:   USDL: III-00-05-23-033-PA
Tues., May 23, 2000
Contact: Leni Uddyback
PHONE: OFFICE: (215) 861-5102

OSHA CITES CONSHOHOCKEN PACKAGING FACILITY FOR ALLEGED HEALTH AND SAFETY VIOLATIONS; PROPOSES $225,000 IN PENALTIES

The U.S. Department of Labor's Occupational Safety and Health Administration has cited Sharp Corporation, Conshohocken, Pa., for alleged safety and health violations and proposed $225,000 in penalties. The company is a packaging contractor employing 430 workers at its Conshohocken facility.

OSHA initiated an investigation on February 17, 2000 in response to an employee complaint alleging that workers were not informed about the chemicals they were handling, or the hazards associated with those chemicals.

Approximately 25 employees work on the packaging of 17 Beta Estradiol Benzoate and Norgestimate-two sex hormones approved by the Federal Drug Administration in October 1999. Exposure to these hormones above the set Occupational Exposure Limit can cause adverse health effects to employees, including damage to the reproductive system.

According to George Tomchick, area director of the Allentown OSHA office, the company was cited for two serious violations, with a total penalty of $10,000 and four willful violations, with a total penalty of $215,000.

The willful citations address the company's failure to provide eye or face protection to guard against chemicals which target the eyes and may be absorbed through the skin and mucous membranes; failure to provide appropriate respirators for employees exposed to chemicals 35 to 150 times the industry-established exposure limit; failure to provide exposure records upon request and failure to provide hazard communication training for employees exposed to 17 Beta Estradiol Benzoate and Norgestimate.

The serious violations are due to the company allowing employee exposure to the hormones to exceed industry-established limits and its failure to conduct a hazard assessment to determine adequate protective equipment for employees.

"By not adhering to industry guidelines, the company took unnecessary chances with the health and safety of the workers exposed to these hormones," says Tomchick.

Willful violations are those committed with an intentional disregard of, or plain indifference to, the requirements of the Occupational Safety and Health Act. A serious violation occurs when there is a substantial probability that death or serious physical harm could result, and the employer knew or should have known of the hazard.

The company has 15 working days from receipt of the citations to decide to comply, request an informal conference with the OSHA area director, or to contest the citations and proposed penalties before the independent Occupational Safety and Health Review Commission.

The investigation was conducted by the Allentown Area Office, 850 North 5th Street, Allentown, Pa. 18102, (610) 776-0592.

# # #

This information will be made available to sensory-impaired individuals upon request. Telecommunications Device for the Deaf. Telephone: (800) 927-9273.


Archive Notice - OSHA Archive

NOTICE: This is an OSHA Archive Document, and may no longer represent OSHA Policy. It is presented here as historical content, for research and review purposes only.

OSHA News Release - (Archived) Table of Contents

Thank You for Visiting Our Website

You are exiting the Department of Labor's Web server.

The Department of Labor does not endorse, takes no responsibility for, and exercises no control over the linked organization or its views, or contents, nor does it vouch for the accuracy or accessibility of the information contained on the destination server. The Department of Labor also cannot authorize the use of copyrighted materials contained in linked Web sites. Users must request such authorization from the sponsor of the linked Web site. Thank you for visiting our site. Please click the button below to continue.

Close